Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
2
×
genentech
2
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
novartis
2
×
san francisco blog main
san francisco top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avapritinib
avexis
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
cancer
cancer drugs
capmatinib
celgene
centers for disease control and prevention
chinook therapeutics
clinical trials
clostridium difficile
What
fda
address
approval
approves
august
bio
biotech
blueprint
busy
cancer
carries
certain
days
decisions
designed
devices
drug
drugs
genetic
latest
legacy
medicines
news
nods
opioid
pass
past
regulatory
ret
roundup
sarepta’s
seven
shkreli’s
signature
signatures
slow
stumble
suits
targeted
targeting
Language
unset
2
×
Current search:
genentech
×
novartis
×
" eli lilly "
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More